<DOC>
	<DOCNO>NCT00169169</DOCNO>
	<brief_summary>Rituximab vs observation high-dose consolidative first-line chemotherapy ( HDC ) autologous stem cell transplantation poor risk diffuse large B-cell lymphoma .</brief_summary>
	<brief_title>Efficacy Study Rituximab After ASCT High-Risk Diffuse Large B-Cell Lymphoma</brief_title>
	<detailed_description>This multicentric , open-label , randomized clinical study , evaluate efficacy safety Rituximab After ASCT patient age 18 59 year previously untreated High-Risk ( aa-IPI 2 3 ) Diffuse Large B-Cell Lymphoma . The duration treatment period approximately 25 week patient follow Death . From 10/99 05/03 , 476 patient enrol . 235 patient assigned receive ACE 241 ACVBP . Among 331 patient , Complete response ( CR+CRu ) induction , receive HDC , 269 randomize ( R2 ) hematological recovery receive either rituximab ( n=139 ) nothing ( n=130 ) . The final analysis perform June 2005 .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Patient histologically proven CD20+ diffuse large B cell lymphoma ( WHO Classification ) . Aged 18 59 year , eligible transplant . Patient previously treat . Age adjust International Prognostic Index equal 2 3 . Having previously sign write informed consent . Women childbearing potential currently practice adequate method contraception . Any histological type lymphoma . Any history treat nontreated indolent lymphoma . Central nervous system meningeal involvement lymphoma . Contraindication drug contain chemotherapy regimen . Poor renal function ( creatinin level &gt; 150mmol/l ) , poor hepatic function ( total bilirubin level &gt; 30mmol/l , transaminase &gt; 2.5 maximum normal level ) unless abnormality relate lymphoma . Poor bone marrow reserve define neutrophil &lt; 1.5 G/l platelet &lt; 100 G/l , unless relate bone marrow infiltration . Any history cancer last 5 year , exception nonmelanoma skin tumor stage 0 ( situ ) cervical carcinoma . Any serious active disease ( accord investigator â€™ decision ) . HIV , HTLV1 HBV related disease . Any organ transplantation inclusion . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Diffuse large B cell lymphoma</keyword>
	<keyword>Rituximab</keyword>
	<keyword>Autotransplant</keyword>
</DOC>